In this Immunotherapy video you will learn the answers to these questions:
- What is neoadjuvent Immunotherapy
- What does neoadjuvent immunotherapy mean for future treatments?
Immunotherapy Before Surgery for Lung Cancer
The Food and Drug Administration (FDA) has approved a treatment for certain lung cancer cancer patients before surgery to remove their lung cancer tumor. This treatment is immunotherapy combined with specific chemotherapy. It is designed for patients with non-small cell lung cancer (NSCLC) who are eligible for surgery. This neoadjuvant immunotherapy (treatment BEFORE surgery) is for patients who have been diagnosed with early-stage disease. Early stage disease is when the tumor is found only in your lung and hasn’t spread to your lymph nodes.
In this Hope With Answers℠ video, you will get answers that will help you and your doctor discuss if immunotherapy treatment before surgery could be right for you.
Watch this video where lung cancer patient and expert advocate, Lysa Buonanno, talks with Dr. Kellie N. Smith of Johns Hopkins Medical Center. They discuss how the ability to treat patients with immunotherapeutics before their tumor is removed surgically can help those patients live longer.
Immunotherapy is a treatment that harnesses your body’s immune system to kill cancer cells. In response to Lysa’s question about what immunotherapy before surgery means for the future of lung cancer treatments, Dr. Smith says,
“We think we’re going to start seeing patients live longer and live disease free for longer after they have the surgery.”
Immunotherapy Before Surgery Hope With Answers℠ Videos
Available online, anytime you need it and anywhere you are, Hope With Answers℠ videos pair lung cancer patients with leading lung cancer doctors. The patients ask the questions that matter most to lung cancer patients. And, they get the answers from doctors who specialize in lung cancer. These lung cancer specialists dedicate their careers to staying up to date on the best tests, the latest effective treatment options, and what exciting things are on the horizon to help lung cancer patients.
The Hope With Answers℠ video series includes videos on immunotherapy before surgery, biomarker testing, staging in lung cancer, targeted therapies, thoracic surgery, ROS1 biomarker, ALK biomarker, clinical trials, and much more. The videos are designed as stepping stones. The Intro videos discuss the most basic information. The intermediate videos offer more profound knowledge. And, the in-depth videos, such as this video about immunotherapy before surgery for lung cancer, provide the most intricate details.